Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma
about
Landscape of somatic retrotransposition in human cancersExpression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.Predicting treatment outcome in classical Hodgkin lymphoma: genomic advancesCancer cytogenetics: methodology revisited.Inhibitor of differentiation 4 (ID4): From development to cancerPrognostic Biomarkers for Hodgkin Lymphoma.High-throughput sequencing for noninvasive disease detection in hematologic malignancies.Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.Aspirin Inhibits LPS-Induced Expression of PI3K/Akt, ERK, NF-κB, CX3CL1, and MMPs in Human Bronchial Epithelial Cells.Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders
P2860
Q29617664-8B94C83C-9572-4BCF-ACF4-BC8CAFA09B08Q35674241-DFBA55C5-2BCA-424D-8466-C1B0F4462CB8Q35955237-0E785FC9-283A-4B9B-B39F-D56CE02F3298Q36629722-E1C8A395-1B93-4D7C-85D8-69751E0A4035Q37683382-CBC0F9FC-F894-4083-9355-96F0C3CA9C2AQ37872044-9A32CA2A-8BF4-4CC4-9069-8C56D3117BD2Q38264921-D7F7A191-AA38-4074-B5E7-C1EC59FC1FCCQ38289940-C213CBD0-789D-4A5F-A516-737C3CEC0914Q38588503-D85843E6-CAC4-44BE-B652-68A15518A56DQ38672646-9F05856F-606B-4C54-96F5-BF6F8779B0A0Q38706339-8BA82C5F-F196-43A4-BC66-EB3E8CBBDC95Q38754419-6840B6D2-0AA9-4359-A56C-92B1E78A5954Q38814461-DEC4A49E-EFF0-442F-B9B4-CF962DE067BFQ38898841-1C955D70-1634-4D80-B4A8-C07C3DA81EBFQ49912597-113C80F6-1C2C-4DD6-BE5A-438A553056E7Q57783666-D54BE53E-7484-4120-B12E-E624FF373009
P2860
Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular karyotypes of Hodgki ...... us refractory Hodgkin lymphoma
@ast
Molecular karyotypes of Hodgki ...... us refractory Hodgkin lymphoma
@en
type
label
Molecular karyotypes of Hodgki ...... us refractory Hodgkin lymphoma
@ast
Molecular karyotypes of Hodgki ...... us refractory Hodgkin lymphoma
@en
prefLabel
Molecular karyotypes of Hodgki ...... us refractory Hodgkin lymphoma
@ast
Molecular karyotypes of Hodgki ...... us refractory Hodgkin lymphoma
@en
P2093
P2860
P1476
Molecular karyotypes of Hodgki ...... us refractory Hodgkin lymphoma
@en
P2093
David D Smith
Dolores B Estrine
Lawrence M Weiss
Maria L Delioukina
Marilyn L Slovak
Norma J Nowak
Stephen J Forman
Victoria Bedell
Ya-Hsuan Hsu
P2860
P304
P356
10.1158/1078-0432.CCR-10-1071
P407
P577
2011-03-08T00:00:00Z